Jae W. Lee

Array ( [id] => 19156132 [patent_doc_number] => 20240148839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-09 [patent_title] => MODIFIED HUMAN SERUM ALBUMIN-THIOREDOXIN FUSION BODY [patent_app_type] => utility [patent_app_number] => 18/282015 [patent_app_country] => US [patent_app_date] => 2022-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6563 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18282015 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18701570 [patent_doc_number] => 11788069 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-17 [patent_title] => In vitro and cell based assays for measuring the activity of botulinum neurotoxins [patent_app_type] => utility [patent_app_number] => 17/691848 [patent_app_country] => US [patent_app_date] => 2022-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 20716 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 116 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19300480 [patent_doc_number] => 20240229049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => NOVEL PROMOTER AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/560239 [patent_app_country] => US [patent_app_date] => 2022-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12169 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18560239 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20213790 [patent_doc_number] => 12410434 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-09-09 [patent_title] => Genelight cultures and extracts and applications thereof [patent_app_type] => utility [patent_app_number] => 17/653395 [patent_app_country] => US [patent_app_date] => 2022-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 32696 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 180 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19281939 [patent_doc_number] => 20240218413 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => MODIFIED POLYPEPTIDE HAVING LYSOZYME ACTIVITY [patent_app_type] => utility [patent_app_number] => 18/558904 [patent_app_country] => US [patent_app_date] => 2022-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13614 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17641966 [patent_doc_number] => 20220169704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-02 [patent_title] => SYSTEM AND METHOD FOR CHARACTERIZING DRUG PRODUCT IMPURITIES [patent_app_type] => utility [patent_app_number] => 17/677499 [patent_app_country] => US [patent_app_date] => 2022-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9020 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17677499 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19121215 [patent_doc_number] => 11965186 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-23 [patent_title] => Nucleic acid-guided nickases [patent_app_type] => utility [patent_app_number] => 17/676218 [patent_app_country] => US [patent_app_date] => 2022-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 18 [patent_no_of_words] => 7242 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17676218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20467622 [patent_doc_number] => 12523657 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => DNA repair blood test for predicting response of lung cancer patients to immunotherapy [patent_app_type] => utility [patent_app_number] => 17/670467 [patent_app_country] => US [patent_app_date] => 2022-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 25 [patent_no_of_words] => 12785 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 222 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17670467 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19977375 [patent_doc_number] => 12344838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-01 [patent_title] => CPF1 complexes with reduced indel activity [patent_app_type] => utility [patent_app_number] => 17/666248 [patent_app_country] => US [patent_app_date] => 2022-02-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 21 [patent_no_of_words] => 175146 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17666248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19050875 [patent_doc_number] => 20240092844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => SEAMLESS INTEGRATION OF ENGINEERED ZINC FINGERS INTO ENDOGENOUS TRANSCRIPTION FACTORS TO COMMANDEER THEIR NATURAL FUNCTIONS [patent_app_type] => utility [patent_app_number] => 18/264207 [patent_app_country] => US [patent_app_date] => 2022-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17354 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18264207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18065744 [patent_doc_number] => 20220396831 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-15 [patent_title] => SYSTEMS AND METHODS FOR ASSESSING A TARGET MOLECULE [patent_app_type] => utility [patent_app_number] => 17/587643 [patent_app_country] => US [patent_app_date] => 2022-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27594 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17587643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17720735 [patent_doc_number] => 20220213455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-07 [patent_title] => THERMOSTABLE CAS9 NUCLEASES [patent_app_type] => utility [patent_app_number] => 17/575952 [patent_app_country] => US [patent_app_date] => 2022-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17575952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18995918 [patent_doc_number] => 11912745 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => ICAM-1 targeted fusion enzymes [patent_app_type] => utility [patent_app_number] => 17/571415 [patent_app_country] => US [patent_app_date] => 2022-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 17 [patent_no_of_words] => 11046 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17571415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17548096 [patent_doc_number] => 20220119437 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => SYNTHESIS OF OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/646093 [patent_app_country] => US [patent_app_date] => 2021-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10934 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17646093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19447284 [patent_doc_number] => 20240307414 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-19 [patent_title] => METHODS AND MATERIALS FOR TREATING PROSTATE CANCER [patent_app_type] => utility [patent_app_number] => 18/267024 [patent_app_country] => US [patent_app_date] => 2021-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19462452 [patent_doc_number] => 20240316121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-26 [patent_title] => MICROORGANISMS ENGINEERED TO REDUCE HYPERPHENYLALANINEMIA [patent_app_type] => utility [patent_app_number] => 18/270102 [patent_app_country] => US [patent_app_date] => 2021-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30816 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -116 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18987774 [patent_doc_number] => 20240059743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-22 [patent_title] => AAV CAPSIDS AND VECTORS [patent_app_type] => utility [patent_app_number] => 18/267373 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18267373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19051241 [patent_doc_number] => 20240093210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-21 [patent_title] => BIOSYNTHESIS METHOD [patent_app_type] => utility [patent_app_number] => 18/039929 [patent_app_country] => US [patent_app_date] => 2021-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23895 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18039929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19083390 [patent_doc_number] => 20240110191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-04-04 [patent_title] => ENGINEERED MICROORGANISMS [patent_app_type] => utility [patent_app_number] => 18/265002 [patent_app_country] => US [patent_app_date] => 2021-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42080 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18265002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18844966 [patent_doc_number] => 20230407370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-21 [patent_title] => GEOMETRIC SYNTHESIS METHODS AND COMPOSITIONS FOR DOUBLE-STRANDED NUCLEIC ACID SEQUENCING [patent_app_type] => utility [patent_app_number] => 18/253864 [patent_app_country] => US [patent_app_date] => 2021-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24240 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18253864 [rel_patent_id] =>[rel_patent_doc_number] =>)